Skip to main content
. 2022 Jul 28;67:104079. doi: 10.1016/j.msard.2022.104079

Fig. 5.

Fig. 5

SARS-CoV-2 spike antibody in patients on anti-CD20 therapy. Legend: A: Association between spike antibody level and CD20 cell count (estimated Spearman's correlation coefficient 0.59 (p<0.001). B: Association between spike antibody level and days since last B-cell infusion (estimated Spearman's correlation coefficient 0.38 (p<0.001).